Losartan Potassium Tablet
Product Images NDC 50090-5480

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 01)

Chemical structure of Losartan Potassium, showing its molecular arrangement including aromatic rings, a potassium ion, and various heteroatoms.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 02)

A line graph comparing the percentage of patients with primary endpoint over study months between Atenolol (dotted line) and Losartan (solid line). The horizontal axis represents study months from 0 to 66, and the vertical axis shows the percentage of patients from 0 to 16%. The graph includes a note on adjusted risk reduction of 13%, with p=0.021.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over a 66-month study period between two drugs: Atenolol (dotted line) and Losartan (solid line). The graph shows Losartan associated with a lower percentage of stroke patients and includes an adjusted risk reduction of 25% with p=0.001.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 04)

A comparative forest plot chart showing event rates and hazard ratios with 95% confidence intervals for Losartan Potassium and Atenolol. Data is stratified by overall results and subgroups including age, gender, race, ISH, diabetes, and history of cardiovascular disease (CVD), focusing on primary composite events and stroke (fatal/non-fatal) outcomes.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 05)

A line graph comparing the percentage of patients with events over 48 months for Losartan versus Placebo. The solid line represents Losartan, and the dashed line represents Placebo, showing risk reduction of 16.1% with a p-value of 0.022.*

FDA Label Image

Label Image (Lbl500905480)

Losartan Potassium 50 mg coated tablets carton label by A-S Medication Solutions with NDC 50090-5480. The label shows the product name, strength, form, and quantity of 30 tablets. Storage instructions advise keeping the product at 77 degrees Fahrenheit, protected from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.